ELV

Elevance Health, Inc.

$429.65

2.73%
SectorHealthcareIndustryHealthcare PlansCountryUnited States

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers.

Source: Yahoo Finance
AI summary

Price & performance

1M+10.6%
3M+14.9%
YTD+27.5%
1Y+31.6%
52-week range—
Beta0.25
Full chart and returns against a benchmark

Q-Score

61/ 100

Quality against peers; 50 is the peer median.

Growth50
Risk70
Performance43
Valuation70
Profitability68
Leverage58
Sentiment39
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$199.1B+12.5%
Net income$5.7B-5.3%
Net margin2.8%-0.5 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

ELVIndustryP/E18.0617.87P/S0.460.47EV/EBITDA16.3711.92P/B2.082.31PEG—0.32
Dividend yield1.61%
Every valuation metric

Earnings

Jan 28next report, before the open
EPS estimate$4.69
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate